跳至主要内容
临床试验/CTRI/2008/091/000090
CTRI/2008/091/000090尚未招募2 期

A double blind, placebo controlled comparative, randomized study to evaluate efficacy & Safety of Colebrookea Oppositifolia (Aceteoside) in acute hepatitis A/B Patients.

Council of Scientific & Industrial Research0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Individuals between 18-60 years of age of either sex suffering from acute hepatitis A/B. Diagnosis will be made on the basis of clinical history or immunological markers.
  • 2.Patients ready to abide by trial procedures and to give informed consent.

排除标准

  • 1.Patients over 60 years or less than 16 years of age.
  • 2.Pregnant or lactating mothers / complicated with Non A & B Hepatitis or Drug / alcoholic hepatitis / chronic active hepatitis.
  • 3.Suspicion of auto â?? immune disease concomitant presence of disease of Cardiovascular System, renal or haemopoietic System or mental disease.
  • 4.Patients using drugs which are likely to affect liver function tests e.g. NSAIDâ??s, Anticonvulsants, anti-diabeitic, statins , hormones, erythromycin etc.

研究者

发起方
Council of Scientific & Industrial Research

相似试验

A Clinical Trial to study the efficacy & safety... | 临床试验